Dosing Phases & Cycling The KLOW research protocol is built as three descending-frequency phases plus an on/off cycle
Because the half-life is 20-30 hours, one injection per day produces relatively stable receptor coverage
This study shows that tumour tissue of origin and oncogenic drivers combine to regulate glutamine metabolism
reconstituted: refrigerate at 28 C (35.646.4 F) and use within 30 days
It is not a drug, supplement, or medical product and is not approved for human or animal use, diagnosis, or treatment
Promotes actin polymerization, cell migration, and structural protein expression, aiding softtissue repair, angiogenesis, and reduced fibrosis